Target

Our patient segment

For CUD indication

Our target population includes 10 % of cannabis users especially young adults with recurrent cannabis use despite adverse impacts on health, relationships, and work.

For fighting pain with cannabis avoiding side effects

In addition, DRT-101 could offer benefits to the 1 in 10 individuals suffering from neuropathic pain who prefer medical cannabis for pain relief but are concerned about potential dependency and cognitive effect risks.